147 related articles for article (PubMed ID: 9724028)
1. Deficient processing and activity of type I insulin-like growth factor receptor in the furin-deficient LoVo-C5 cells.
Lehmann M; André F; Bellan C; Remacle-Bonnet M; Garrouste F; Parat F; Lissitsky JC; Marvaldi J; Pommier G
Endocrinology; 1998 Sep; 139(9):3763-71. PubMed ID: 9724028
[TBL] [Abstract][Full Text] [Related]
2. Lack of integrin alpha-chain endoproteolytic cleavage in furin-deficient human colon adenocarcinoma cells LoVo.
Lehmann M; Rigot V; Seidah NG; Marvaldi J; Lissitzky JC
Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):803-9. PubMed ID: 8760366
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
Garrouste FL; Remacle-Bonnet MM; Lehmann MM; Marvaldi JL; Pommier GJ
Endocrinology; 1997 May; 138(5):2021-32. PubMed ID: 9112401
[TBL] [Abstract][Full Text] [Related]
4. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.
Lissitzky JC; Luis J; Munzer JS; Benjannet S; Parat F; Chrétien M; Marvaldi J; Seidah NG
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):133-8. PubMed ID: 10657249
[TBL] [Abstract][Full Text] [Related]
5. Processing of wild-type and mutant proinsulin-like growth factor-IA by subtilisin-related proprotein convertases.
Duguay SJ; Milewski WM; Young BD; Nakayama K; Steiner DF
J Biol Chem; 1997 Mar; 272(10):6663-70. PubMed ID: 9045697
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions.
Khatib AM; Siegfried G; Prat A; Luis J; Chrétien M; Metrakos P; Seidah NG
J Biol Chem; 2001 Aug; 276(33):30686-93. PubMed ID: 11402025
[TBL] [Abstract][Full Text] [Related]
7. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells.
Stracke ML; Engel JD; Wilson LW; Rechler MM; Liotta LA; Schiffmann E
J Biol Chem; 1989 Dec; 264(36):21544-9. PubMed ID: 2557332
[TBL] [Abstract][Full Text] [Related]
8. Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain.
Sucic JF; Moehring JM; Inocencio NM; Luchini JW; Moehring TJ
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):639-47. PubMed ID: 10215603
[TBL] [Abstract][Full Text] [Related]
9. Functional and immunological distinction between insulin-like growth factor I receptor subtypes in KB cells.
Garofalo RS; Barenton B
J Biol Chem; 1992 Jun; 267(16):11470-5. PubMed ID: 1317868
[TBL] [Abstract][Full Text] [Related]
10. Activation of phosphorylation of plasma membrane insulin-like growth factor-I receptors in the kidney of Syrian hamsters by diethylstilbestrol.
Chen CW; Roy D
Carcinogenesis; 1995 Jun; 16(6):1339-44. PubMed ID: 7788852
[TBL] [Abstract][Full Text] [Related]
11. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K
Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140
[TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor 1 (IGF-1) receptor is responsible for mediating the effects of insulin, IGF-1, and IGF-2 in Xenopus laevis oocytes.
Janicot M; Flores-Riveros JR; Lane MD
J Biol Chem; 1991 May; 266(15):9382-91. PubMed ID: 1851744
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.
Casella SJ; Han VK; D'Ercole AJ; Svoboda ME; Van Wyk JJ
J Biol Chem; 1986 Jul; 261(20):9268-73. PubMed ID: 3013881
[TBL] [Abstract][Full Text] [Related]
14. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins.
Doré S; Pelletier JP; DiBattista JA; Tardif G; Brazeau P; Martel-Pelletier J
Arthritis Rheum; 1994 Feb; 37(2):253-63. PubMed ID: 7510486
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin.
Komada M; Hatsuzawa K; Shibamoto S; Ito F; Nakayama K; Kitamura N
FEBS Lett; 1993 Aug; 328(1-2):25-9. PubMed ID: 8344430
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
Valverde AM; Teruel T; Lorenzo M; Benito M
Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
[TBL] [Abstract][Full Text] [Related]
17. Furin-mediated cleavage of Pseudomonas exotoxin-derived chimeric toxins.
Chiron MF; Fryling CM; FitzGerald D
J Biol Chem; 1997 Dec; 272(50):31707-11. PubMed ID: 9395513
[TBL] [Abstract][Full Text] [Related]
18. Insulin and insulin-like growth factors stimulate in vivo receptor autophosphorylation and tyrosine phosphorylation of a 70K substrate in cultured fetal chick neurons.
Kenner KA; Heidenreich KA
Endocrinology; 1991 Jul; 129(1):301-11. PubMed ID: 1711464
[TBL] [Abstract][Full Text] [Related]
19. Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors.
Perdue JF; LeBon TR; Kato J; Hampton B; Fujita-Yamaguchi Y
Endocrinology; 1991 Dec; 129(6):3101-8. PubMed ID: 1659523
[TBL] [Abstract][Full Text] [Related]
20. Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226.
Freund GG; Kulas DT; Mooney RA
J Immunol; 1993 Aug; 151(4):1811-20. PubMed ID: 7688386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
